From: Proceedings of Réanimation 2020, the French Intensive Care Society International Congress
Empiric antibiotic | Number | Percentage (%) | Adapted antibiotic | Number | Percentage (%) |
---|---|---|---|---|---|
Imipenem Colistin Gentamicin Cefotaxime | 8 1 1 3 | 22.2 2.8 2.8 8.3 | Imipenem Cefotaxime Colistin Piperacillin/tazobactam Amikacin Gentamycin | 2 2 2 2 1 1 | 5.6 5.6 5.6 5.6 2.8 2.8 |
Imipenem + gentamicin Imipenem + amikacin Imipenem + colistin Tigecycline + colistin Amoxicillin/clavulanic acid + amikacin Ciprofloxacin + colistin Ciprofloxacin + rifampicin Imipenem + bactrim Cefotaxime + metronidazol Cefotaxime + ciprofloxacin | 4 3 2 2 1 1 1 1 1 1 | 11.1 8.3 5.6 5.6 2.8 2.8 2.8 2.8 2.8 2.8 | Imipenem + gentamicin Imipenem +amikacin Imipenem + tygecycline Imipenem + colistin Tygecycline + colistin Ciprofloxacin + gentamicin Ciprofloxacin + tygecycline Ciprofloxacin + imipenem Cefotaxime + gentamicin Colistine + Amikacin Ertapenem + gentamycin Piperacillin/tazobactam + fosfomycin | 5 4 2 1 1 1 1 1 1 1 1 1 | 13.9 11.1 8.3 5.6 5.6 5.6 2.8 2.8 2.8 2.8 2.8 2.8 |
Colistin + rifampicin + Ciprofloxacin Colistin + vancomycin + metronidazol Imipenem + gentamicin + tygecycline | 1 1 1 | 2.8 2.8 2.8 | Ceftazidime + amikacin + colistine Piperacillin/tazobactam + ciprofloxacin + colistin Piperacillin/tazobactam + Imipenem + levofloxacine | 1 1 1 | 2.8 2.8 2.8 |
No use of empiric antibiotic | 3 | 8.3 | P. mirabilis not treated | 3 | 8.3 |